Bonnie L Hall
Overview
Explore the profile of Bonnie L Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ingusci S, Hall B, Goins W, Cohen J, Glorioso J
Handb Clin Neurol
. 2024 Sep;
205:59-81.
PMID: 39341663
Brain diseases with a known or suspected genetic basis represent an important frontier for advanced therapeutics. The central nervous system (CNS) is an intricate network in which diverse cell types...
2.
Ingusci S, Hall B, Cohen J, Glorioso J
Mol Ther Oncol
. 2024 Apr;
32(1):200761.
PMID: 38596286
Oncolytic herpes simplex viruses (oHSVs) have emerged as leading cancer therapeutic agents. Effective oHSV virotherapy may ultimately require both intratumoral and systemic vector administration to target the primary tumor and...
3.
Marzulli M, Hall B, Zhang M, Goins W, Cohen J, Glorioso J
Mol Ther Methods Clin Dev
. 2023 Jul;
30:208-220.
PMID: 37519407
Transductional targeting of herpes simplex virus (HSV)-based gene therapy vectors offers the potential for improved tissue-specific delivery and can be achieved by modification of the viral entry machinery to incorporate...
4.
Lubin J, Zardecki C, Dolan E, Lu C, Shen Z, Dutta S, et al.
Proteins
. 2021 Sep;
90(5):1054-1080.
PMID: 34580920
Understanding the molecular evolution of the SARS-CoV-2 virus as it continues to spread in communities around the globe is important for mitigation and future pandemic preparedness. Three-dimensional structures of SARS-CoV-2...
5.
Jackson J, Hall B, Marzulli M, Shah V, Bailey L, Chiocca E, et al.
Mol Ther Oncolytics
. 2021 Sep;
22:444-453.
PMID: 34553031
Oncolytic herpes simplex viruses (oHSVs) have demonstrated efficient lytic replication in human glioblastoma tumors using immunodeficient mouse models, but early-phase clinical trials have reported few complete responses. Potential reasons for...
6.
Ringer McDonald A, Roberts R, Koeppe J, Hall B
Curr Opin Struct Biol
. 2021 Aug;
72:39-45.
PMID: 34461592
The use of theory and simulation in undergraduate education in biochemistry, molecular biology, and structural biology is now common, but the skills students need and the curriculum instructors have to...
7.
Lubin J, Zardecki C, Dolan E, Lu C, Shen Z, Dutta S, et al.
bioRxiv
. 2020 Dec;
PMID: 33299989
Three-dimensional structures of SARS-CoV-2 and other coronaviral proteins archived in the Protein Data Bank were used to analyze viral proteome evolution during the first six months of the COVID-19 pandemic....
8.
Hall B, Leronni D, Miyagawa Y, Goins W, Glorioso J, Cohen J
Int J Mol Sci
. 2020 Nov;
21(22).
PMID: 33233403
Oncolytic herpes simplex viruses (oHSV) are under development for the treatment of a variety of human cancers, including breast cancer, a leading cause of cancer mortality among women worldwide. Here...
9.
Burley S, Bromberg Y, Craig P, Duffy S, Dutta S, Hall B, et al.
Biochem Mol Biol Educ
. 2020 Aug;
48(5):511-513.
PMID: 32797732
No abstract available.
10.
Tuzmen C, Cairns T, Atanasiu D, Lou H, Saw W, Hall B, et al.
Mol Ther Methods Clin Dev
. 2020 Feb;
16:145-154.
PMID: 32042851
Effective oncolytic virotherapy may require systemic delivery, tumor targeting, and resistance to virus-neutralizing (VN) antibodies. Since herpes simplex virus (HSV) glycoprotein D (gD) is the viral attachment/entry protein and predominant...